Johnson & Johnson’s (NYSE: LLY) Imbruvica is a covalent BTK inhibitor. Pirtobrutinib met its primary endpoint of non-inferiority on overall response rate (ORR) compared to ibrutinib (87.0% versus 78.5 ...

Johnson & Johnson (NYSE:JNJ) and Eli Lilly (NYSE:LLY) are utilizing Nvidia (NVDA) technology to either enhance their products or assist in the development of new treatments, the chipmaker's CEO said ...

Some of its top products are diabetes medications, weight loss drugs, obesity treatments, and antidepressants such as Prozac.

Lilly posted 53.9% revenue growth and 480% net income growth driven by GLP-1 drugs Mounjaro and Zepbound. Lilly’s operating margin hit 48.3% versus J&J’s 30.2%. Gross margin reached 82.9%. Novo ...

The 2025 NextGen Supply Chain Conference is bringing together a strong lineup of speakers in the life sciences and healthcare spaces as one of its four focus areas for this year’s conference. Among ...

Eli Lilly (LLY), Pfizer (PFE), and Johnson & Johnson (JNJ) have secured spots on China’s drug catalog, with a total of 19 medicines making the list, Amber Tong of Bloomberg reports. The government did ...

Link: https://www.zacks.com/commentary/2877179/4-large-cap-pharma-stocks-to-watch-as-industry-recovery-gains-steam The drug and biotech sector has recovered somewhat ...

Link: https://www.zacks.com/commentary/2799269/3-large-drug-stocks-to-watch-as-the-industry-shows-some-recovery The drug and biotech sector has recovered in the past ...